<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<link rel="stylesheet" type="text/css" href="stylesheets/style.css">
	<script type="text/javascript" src="scripts/script.js"></script>
	<title>final</title>
</head>
<body>
	<div class="container">
		<header>
			<nav>
				<div class="tab active_t">
					<p>Graphics</p>
				</div>
				<div class="tab">
					<p>Calculator</p>
				</div>
				<div class="tab">
					<p>Competitors</p>
				</div>
			</nav>	
		</header>
		<section>
			<article class="page active_p">
				<div class="graphics_header">
					<h1>Xarelto<sup>&reg;</sup>: An Effective Treatment Option<br>in Your VTE Patients with Canser<sup>a,8</sup></h1>
				</div>
				<div class="graphics_content">
					<div class="sidebar">
						<p>%PATIENTS<sup>b</sup></p>	
					</div>
					<div class="diagram">
						<div class="y_axis">
							<ul>
								<li>8 -</li>
								<li>7 -</li>
								<li>6 -</li>
								<li>5 -</li>
								<li>4 -</li>
								<li>3 -</li>
								<li>2 -</li>
								<li>1 -</li>
								<li>0</li>
							</ul>
						</div>
						<div class="diagram_header">
							<h2>HR 0.69;<br>95% CL 0.36-1.33</h2>
						</div>
						<div class="left_column">
							<p>7.1</p>
							<p>n=20/281</p>
							<p>ENOXAPARIN/<br>VKA</p>
						</div>
						<div class="right_column">
							<p>5.1</p>
							<p>n=16/316</p>
							<p>XarelTO</p>
						</div>
						<div class="x_axis">
							<p>Cancer</p>
						</div>
						
					</div>
				</div>
				<div class="graphics_footer">
					<p><sup>a</sup>Xarelto is contraindicated in lesions or conditions, if they are considered to be a significant for major<br> bleeding, which may include the presence of malignant neoplasms at hirisk of bleeding.</p>
					<p><sup>b</sup>Outcome:symptomatic, recurrent VTE.</p>
				</div>
			</article>
			<article class="page">
				<div class="calculator_header">
					<h1>Xarelto<sup>&reg;</sup> Estimator of Resources Saved</h1>
				</div>
				<div class="calculator_content">
					<form class="left_calculator" action="">
						<div class="head_calculator">
							<input type="text">
							<button class="calculate">CALCULATE</button>
							<a href="#">?</a>
						</div>
						<div class="about_calculator">
							<p>Assumptions to estimate calculations: proportion of patients with DVT contraindicated<br>for Xarelto or LMWH/VKA<sup>1,2</sup> = 7.5%</p>
							<p><strong>Number of patients with DVT - 7.5% =</strong> <span>[A]</span> Total number of DVT patients<br> eligible for dual LMWH/VKA or Xarelto</p>
						</div>
						<div class="head_fields_calculator" id="Injections_left_calculator">
							<h2>Injections avoided<sup>3-7</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>Injections avoided = numbers of LMWH injections received by cancer patients<br> with DVT + LMWH injections received by DVT patients without canser</p>
						</div>
						<div class="head_fields_calculator" id="inr_left_calculator">
							<h2>INR clinic visits avoided<sup>3, 7, 8</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>INR clinic visits avoided = numbers of DVT patients eligible for<br>VKA treatment &times; number of INR monitoring visits per patients</p>
						</div>
						<div class="head_fields_calculator" id="nurse_left_calculator">
							<h2>Nurse visits avoided<sup>9</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>Nurse assistance visits avoided = numbers of non-canser DVT patients eligible<br> for initial LMWH treatment &times; proportion of these patients treated by nurses<br> in their own homes &times; mean number of LMWH injections administered</p>
						</div>
						<div class="head_fields_calculator" id="hospital_left_calculator">
							<h2>Hopital bed days saved<sup>10</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>Hopital bed days saved = numbers of eligible DVT &times; proportion of DVT<br> patients hospitaled &times; number of hospital bed days saved per DVT patient<br> treated with Xalerto</p>
						</div>
					</form>
					<form action="" class="right_calculator">
						<div class="head_calculator">
							<input type="text">
							<button class="calculate">CALCULATE</button>
							<a href="#">?</a>
						</div>
						<div class="about_calculator">
							<p>Assumptions to estimate calculations: proportion of patients with PE contraindicated<br>for Xarelto or LMWH/VKA<sup>1,2</sup> = 15%</p>
							<p><strong>Number of patients with PE - 15% =</strong> <span>[A]</span> Total number of PET patients eligible<br> for dual LMWH/VKA or Xarelto</p>
						</div>
						<div class="head_fields_calculator" id="Injections_right_calculator">
							<h2>Injections avoided<sup>3-6, 11</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>Injections avoided = numbers of LMWH injections received by cancer patients<br> with PE + LMWH injections received by PE patients without canser</p>
						</div>
						<div class="head_fields_calculator" id="inr_right_calculator">
							<h2>INR clinic visits avoided<sup>3, 8, 11</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>INR clinic visits avoided = numbers of PE patients eligible for VKA<br>treatment &times; number of INR monitoring visits per patients</p>
						</div>
						<div class="head_fields_calculator" id="hospital_right_calculator">
							<h2>Hopital bed days saved<sup>10</sup></h2>
							<output></output>
						</div>
						<div class="about_fields_calculator">
							<a href="#">+</a>	
							<p>Hopital bed days saved = numbers of eligible PE &times; proportion of PE<br> patients hospitaled &times; number of hospital bed days saved per PE patient<br> treated with Xalerto</p>
						</div>
					</form>
					<form action="" class="combined_calculator">
						<div class="combined_calculator">
							<h2>Combined DVT + PE Resources Saved</h2>
						</div>
						<div class="injections">
							<h3>Injections avoided<sup>3-7, 11</sup></h3>
							<output></output>
						</div>
						<div class="inr_clinic">
							<h3>INR clinic visits avoide<sup>3, 7, 8, 11</sup> </h3>
							<output></output>
						</div>
						<div class="nurse">
							<h3>Nurse visits avoided<sup>9</sup></h3>
							<output></output>
						</div>
						<div class="hospital">
							<h3>Hopital bed days saved<sup>10</sup></h3>
							<output></output>
						</div>
					</form>
				</div>
				<div class="calculator_footer">
					<p>Numbers provided are based on general epidemiological research and on clinical trial experience from the Phase III programme with Xarelto. Healthcare practice<br>may be different in your country(both before and after introduction Xarelto), and thus the estimation may not reflect your country's perspective.</p>
					<p>Actual costs are not included.</p>
				</div>
			</article>
			<article class="page">
				<div class="competitors_header">
					<h1>Xarelto<sup>&reg;</sup> DVT Patients Reported Higher Satisfaction<sup>a,16</sup></h1>
				</div>
				<div class="competitors_content">
					
				</div>
				<div class="competitors_footer">
					<p><sup>a</sup>Patients participating in EINSTEIN DVT trial had confirmed acute symptomatic DVT without symptomatic PE and completed two measures of treatment satisfaction;<br> ATS (Anti Clot Treatment Scale) and TSQM (Treatment Satisfaction Questionnaire for Medication) in follow up visits.<sup>5, 16</sup></p>
					<p><sup>b</sup>Score values given for burdens and benefits measured by ACTS; effectiveness, side effects, convenience and global satisfaction measured by TSQM scale.<sup>16</sup></p>
				</div>
			</article>
		</section>
		<script type="text/javascript" src="scripts/script.js"></script>
	</div>
</body>
</html>
